why choose us

First received: October 16, 2023

Clinical Trial: Palbociclib and Pembrolizumab in Undifferentiated Pleomorphic Sarcoma (UPS)

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Undifferentiated Pleomorphic Sarcoma

Study Type: INTERVENTIONAL


Official Title: Phase Ib Trial Evaluating the Combination of CDK4 Inhibitor With Immunotherapy in Patients With Undifferentiated Pleomorphic Sarcoma (UPS)

Brief Summary: This is a single-arm open-label window of opportunity clinical study assessing the impact of pre- treatment with palbociclib

Read more